Hormone replacement therapy for postmenopausal osteoporosis
SONG Zhiqin
HU Ping
Abstract：Postmenopausal osteoporosis is mainly due to the loss of ovarian function or failure, decreased estrogen levels caused by broken bone resorption of bone cells than of osteoblasts in bone formation, with progressive bone loss, bone trabecular degenerative diseases, osteoporosis, increased osteopsathyrosis and increased risk of fracture for the clinical features of systemic disease.Numbers of clinical postmenopausal women do not attach importance to the severity of osteoporosis,which delay the best time of the prevention and treatment, increase the complexity of the osteoporosis treatment. Hormone replacement therapy for the prevention and treatment of osteoporosis in postmenopausal women is one of effective method,especially for prevention of early postmenopausal bone loss has be-come a first-line treatment,and has advantages of low cost and high security.Hormone replacement therapy can increase not only in patients with bone mineral density, slow bone loss,but also can make hints of bone destruction markers, such as the serum calcitonin and alkaline phosphatase levels decrease obviously, which play a role in prevention and treatment of postmenopausal osteoporosis and fractures.In this paper, the changes of osteoporosis in postmenopausal women is reviewed.
Keywords：Postmenopausal womenOsteoporosisBone mineral density
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 302-305 )